Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-11

Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating the safety, tolerability, and preliminary activity of AGX101 in adults with advanced solid tumors. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AGX101

Snippet

Sponsor: Angiex, Inc. | Conditions: Cancer, Advanced Cancer | Phase 1 | Status: RECRUITING